The road to precision oncology

The ultimate goal of precision medicine is to use population-based molecular, clinical and other data to make individually tailored clinical decisions for patients, although the path to achieving this goal is not entirely clear. A new study shows how knowledge banks of patient data can be used to make individual treatment decisions in acute myeloid leukemia.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: The knowledge bank approach.

References

  1. 1

    Gerstung, M. et al. Nat. Genet. 49, 332–340 (2017).

    CAS  Article  Google Scholar 

  2. 2

    Marx, V. Nature 524, 503–505 (2015).

    CAS  Article  Google Scholar 

  3. 3

    Collins, F.S. & Varmus, H. N. Engl. J. Med. 372, 793–795 (2015).

    CAS  Article  Google Scholar 

  4. 4

    The Global Alliance for Genomics and Health. Science 352, 1278–1280 (2016).

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrew V Biankin.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Biankin, A. The road to precision oncology. Nat Genet 49, 320–321 (2017). https://doi.org/10.1038/ng.3796

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing